ArticleThe Journal of biological chemistry2017

A Quininib Analogue and Cysteinyl Leukotriene Receptor Antagonist Inhibits Vascular Endothelial Growth Factor (VEGF)-independent Angiogenesis and Exerts an Additive Antiangiogenic Response with Bevacizumab.

Clare T Butler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.